Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia

Archives of Disease in Childhood

Volumn 95, Issue 10, 2010, Pages 805-809

  Elmantaser, M ^a   Stewart, G ^a   Young, D ^b   Duncan, R ^a   Gibson, B ^a   Ahmed, S F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE DISEASE; BONE NECROSIS; CANCER CHEMOTHERAPY; CHILD; DISEASE PREDISPOSITION; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUSCULOSKELETAL PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DISEASES; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; MALE; OSTEONECROSIS; PAIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 77957361820     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.172528     Document Type: Article

References (23)

1. Brenner H, Kaatsch P, Burkhardt-Hammer T, et al. Long-term survival of children with leukemia achieved by the end of the second millennium. Cancer 2001;92:1977-83.
2. Sala A, Barr RD. Osteopenia and cancer in children and adolescents: the fragility of success. Cancer 2007;109:1420-31.
3. Davies JH, Evans BA, Jenney ME, et al. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2005;63:1-9.
4. Mushtaq T, Ahmed SF. The impact of corticosteroids on growth and bone health. Arch Dis Child 2002;87:93-6.
5. Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1998;83:3121-9.
6. Ahmed SF, Tucker P, Mushtaq T, et al. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin Endocrinol (Oxf) 2002;57:185-91.
7. Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001;19:3066-72.
8. Högler W, Wehl G, van Staa T, et al. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer 2007;48:21-7.
9. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, et al. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006;46:88-93.
10. Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 2005;129:734-45.
11. Rogalsky RJ, Black GB, Reed MH. Orthopaedic manifestations of leukemia in children. J Bone Joint Surg Am 1986;68:494-501.
12. Atkinson SA, Fraher L, Gundberg CM, et al. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 1989;114:793-800.
13. Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995;126:557-64.
14. van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-10.
15. Ward LM. Osteoporosis due to glucocorticoid use in children with chronic illness. Horm Res 2005;64:209-21.
16. Junkins EP Jr, Stotts A, Santiago R, et al. The clinical presentation of pediatric thoracolumbar fractures: a prospective study. J Trauma 2008;65:1066-71.
17. Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 2009;24:1326-34.
18. Wallace AM, Tucker P, Williams DM, et al. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2003;58:770-6.
19. Mattano LA Jr, Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000;18:3262-72.
20. Kawai K, Tamaki A, Hirohata K. Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J Bone Joint Surg Am 1985;67:755-63.
21. Nishida K, Yamamoto T, Motomura G, et al. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res 2008;466:1054-8.
22. Hanada T, Horigome Y, Inudoh M, et al. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during L-asparaginase therapy. Eur J Pediatr 1989;149:162-3.
23. Kelly HW, Van Natta ML, Covar RA, et al. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008;122:e53-61.